Clare McGrane
M3 Biotechnology Secures $1.4M from Alzheimer’s Drug Discovery Foundation to Launch Clinical Trials for Innovative Alzheimer's Therapy
Seattle-based M3 Biotechnology secured an additional $1.4 million from the Alzheimer’s Drug Discovery Foundation to prepare clinical trials for its novel Alzheimer’s therapy aimed at stopping neuron deterioration. This funding follows a previous $14 million raised, supporting the company’s advancement toward potentially halting disease progression rather than just treating symptoms.
Seattle Startup Fashwire Raises $725,000 to Launch Fashion App Providing Designers Real-Time Consumer Feedback
Seattle startup Fashwire raised $725,000 in a seed round to develop a fashion app that connects designers with consumers for real-time feedback. The app, which has 6,000 users and 1,400 designers in beta, plans a wider launch in August and will generate revenue primarily through designer subscriptions.
GeekWire Awards 2017 Finalists Highlight Pacific Northwest Tech Innovation, Winners Publicly Voted and Revealed May 4 at MoPop
The 2017 GeekWire Awards finalists showcase the Pacific Northwest's tech industry's strength, especially in cloud technology, with winners decided by public votes and announced at a May 4 ceremony at MoPop.
UW Spinout Bellwether Bio Raises $2.7M Seed to Commercialize Non‑Invasive Liquid Biopsy Founded by Jay Shendure and Matthew Snyder
Bellwether Bio, a University of Washington spinout founded by genomics researcher Jay Shendure and technologist Matthew Snyder, is commercializing a non-invasive liquid biopsy that analyzes tumor DNA in blood and raised an oversubscribed seed round totaling $2.7 million per an SEC filing. Investors include the UW’s W Fund, WRF Capital and Bioeconomy Capital, and the company says it is collaborating with cancer diagnostics firms to validate and commercialize the technology.
Biomatics Capital Partners closes $200M fund to back genomics, digital health and data-driven healthcare startups
Julie Sunderland and Dr. Boris Nikolic, former Gates Foundation advisors, launched Seattle-based Biomatics Capital Partners and closed a $200 million fund to make early-stage investments in up to 20 life-science companies focused on genomics, digital health, and data-driven healthcare.
UW spinout DMD Therapeutics raises $400,000 from three foundations to advance DMD-813 toward human trials
DMD Therapeutics, a University of Washington spinout led by Ron Berenson, raised $400,000 from three DMD-focused foundations to advance its lead candidate DMD-813 — which showed positive results in mouse studies — toward human trials and early manufacturing.
Tencent Leads $3M Investment in Innovega as AR Contact-Lens eMacula Nears FDA Review
Innovega, maker of the eMacula AR contact-lens and glasses system, has quietly raised about $3 million in a round led by Tencent as it prepares for commercial launch after completing clinical trials and awaiting FDA review; the company has previously raised roughly $7 million from government agencies, bringing total funding to about $10 million.
Neurosurgery Professor Peter Thompson’s Stealth Biotech Silverback Therapeutics Raised $10M as Part of a $60M Round
Peter Thompson, a University of Washington neurosurgery professor and investor, co-founded stealth biotech Silverback Therapeutics which raised $10 million (part of a disclosed $60 million round) and lists staff with immunotherapy and oncology experience, though the company’s focus and co-founder remain undisclosed.
Vesiflo raises $2.4M toward $3M round to scale FDA-approved inFlow device that frees neurogenic bladder patients from catheters
Vesiflo, a Redmond medical device startup, has raised $2.4 million toward a $3 million round to manufacture and distribute its FDA-approved inFlow urethral device, which helps patients with neurogenic bladder urinate without catheters and reportedly reduces infections and improves quality of life.
UW Tacoma Spinout KenSci Raises $8.5M Series A to Scale ML Platform Predicting Patient Clinical, Financial, and Operational Risks
KenSci, a University of Washington Tacoma spinout founded by Ankur Teredesai and Samir Manjure, raised $8.5 million in Series A funding to scale its machine-learning risk prediction platform that forecasts clinical, financial, and operational patient risks. The startup aggregates data from devices and electronic medical records to help health systems move from reactive disease management to proactive care.
Pavia Systems raises $4M led by Eileses Capital to expand HeadLight deployment
Pavia Systems raised $4 million to accelerate deployment of its HeadLight construction software, a mobile and desktop platform that digitizes field documentation and real-time updates for infrastructure projects.
Voyager Capital Hires Silicon Valley Veteran James Newell to Lead Pacific Northwest Investment Focus
James Newell, a Seattle native and former Silicon Valley investor, joins Voyager Capital's Seattle office as partner to enhance the firm's focus on Pacific Northwest startups. Voyager Capital aims to leverage Newell's Silicon Valley experience to strengthen ties between Seattle's growing tech scene and Silicon Valley.
ChoiceMap founder Jonathan Jackson raises $100,000 from angel Tom Callaghan to advance patient-centered treatment decision app
ChoiceMap, founded by cognitive-science researcher Jonathan Jackson, turned a personal decision-making algorithm into an app that helps patients and physicians choose treatment options aligned with patient preferences. The startup raised about $100,000 from angel investor Tom Callaghan to support growth and clinical trials at the University of Pittsburgh Medical Center.
Fred Hutch spinout Nohla Therapeutics raises $43.5M Series A led by Arch to advance cord‑blood leukemia therapies
Nohla Therapeutics, a Fred Hutch spinout, raised $43.5 million in a Series A led by Arch Venture Partners to advance cord‑blood transplant therapies for high‑risk leukemia, funding two lead candidates including Phase 2 NLA-101 and a second program slated for trials in 2018.
Former Expedia VP Jeff Warren’s Stealth Startup Closer Mobile Raises $325,106 Including Funding from Idealab
Former Expedia executive Jeff Warren has launched a stealth startup called Closer Mobile, building an app described as a “Kayak for ride-hailing” to compare and book multiple transportation services. An SEC filing shows Closer Mobile raised $325,106, including investment from Bill Gross’ incubator Idealab, and the company plans to reveal more details later this year or early next while actively hiring.
Zymergen opens Seattle engineering center in World Trade Center, starts with three employees and active hiring
Zymergen has opened a Seattle engineering office in the World Trade Center with three staff and is hiring engineers to expand a team focused on data science and software to support its biological engineering work designing novel molecules and materials.
Sound Pharmaceuticals raises $30M to advance SPI-1005 (Ebselen) into mid/late trials for noise-induced hearing loss
Sound Pharmaceuticals is raising $30 million (with just over $4 million committed so far) to fund mid- and late-stage trials of SPI-1005, an Ebselen-containing drug aimed at preventing or reversing noise-induced hearing loss. Ebselen can enter the cochlea and cross the blood-brain barrier, so SPI-1005 is being advanced for hearing loss while the compound is also studied for other ear disorders and bipolar disorder.
BrightVolt opens Series B with $5M lead from New Science Ventures, total funding tops $20M
BrightVolt, a Redmond startup making ultra-thin, solid-state Flexion batteries used in over 10,000 products, has opened a Series B round with a $5 million lead investment from New Science Ventures, bringing total funding to over $20 million. The company will use the funds to scale manufacturing and prepare for increased demand across IoT, medical devices, wearables, sensors and labels.
Seattle Startup Nexgenia Raises $2M to Broaden Polymer Reagent Technology for Immunotherapy Applications
Seattle biotech startup Nexgenia, led by CEO Ron Myers, raised $2 million to expand its polymer-based reagents for sorting cells in immunotherapy production to new applications. The funding, led by the W Fund and Washington Research Foundation, will support further research into diverse uses of their technology beyond cancer treatment.
Seattle Serial Entrepreneur Ron Berenson’s New UW Spin‑Off DMD Therapeutics Files to Raise $600,000
Ron Berenson has launched a new Seattle biotech startup, DMD Therapeutics, which filed to raise $600,000 with Berenson listed as president; the company is a University of Washington spin-off currently operating in stealth mode. Berenson is a serial entrepreneur who leads several other biotech and medical companies and has a long history in Seattle’s biotech scene.
Keiretsu Capital closes $4.2M second co-investment fund, raising total to $10M and investing $850K in 13 startups
Keiretsu Capital closed its second co-investment fund at $4.2 million, bringing total capital to over $10 million from 150+ global investors and already investing $850,000 in 13 early-stage tech and life-science companies.
University of Washington Spinout C-SATS Raises $3.2M to Expand Video-Based Surgical Performance Review Platform
C-SATS, a University of Washington spinout that uses operating-room video and paid expert reviewers to assess surgeons’ technical and communication skills, raised $3.2 million to expand staff and technology after a prior $2.5 million round. The Seattle startup’s platform is now used at about 100 hospitals and was recently adopted by UW Medicine departments for broader clinical applications.
Kineta secures undisclosed NIAID funding to advance IRF-3–based antivirals against Zika
Kineta, a Seattle biotech, received undisclosed NIAID funding to expand research on its Innate Immune Antiviral program targeting Zika by leveraging IRF-3–based broad-spectrum antivirals that showed efficacy against other flaviviruses like Dengue and West Nile.
Former Nuance VP Harjinder Sandhu raises $2.5M led by Madrona for stealth AI healthcare startup Saykara
Former Nuance healthcare technologist Harjinder Sandhu has raised $2.5 million from investors led by Madrona Venture Group for Saykara, a stealth Seattle AI healthcare startup building machine-intelligence tools to change how physicians interact with medical systems.
Joylux raises $2 million, hires marketing VP and advisor ahead of U.S. launch of vSculpt pelvic‑floor device
Joylux raised $2 million to prepare a U.S. launch of vSculpt, a sonic-vibration device that treats pelvic floor weakening and has already launched successfully in Canada. The company hired Heather Dazell as VP of marketing, added Deborah Reisenthel to its advisory board, and is seeking FDA clearance while having offered vSculpt for U.S. pre-sale at $345.